Mercer Global Advisors
RVNC

Mercer Global Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Mercer Global Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,278
Closed -$53.4K – 2316
2024
Q3 		$53.4K Sell
10,278
-8,022
-44% -$39.9K ﹤0.01% 1913
2024
Q2 		$47K Buy
18,300
+32
+0.2% +$109 ﹤0.01% 1915
2024
Q1 		$90K Buy
18,268
+200
+1% +$1.18K ﹤0.01% 1859
2023
Q4 		$159K Sell
18,068
-35
-0.2% -$287 ﹤0.01% 1870
2023
Q3 		$208K Buy
18,103
+8,942
+98% +$172K ﹤0.01% 1746
2023
Q2 		$232K Buy
9,161
+100
+1% +$3.12K ﹤0.01% 1659
2023
Q1 		$292K Sell
9,061
-2,034
-18% -$63.4K ﹤0.01% 1530
2022
Q4 		$205K Buy
11,095
+289
+3% +$6.61K ﹤0.01% 1704
2022
Q3 		$292K Buy
10,806
+71
+0.7% +$1.44K ﹤0.01% 1428
2022
Q2 		$148K Sell
10,735
-1,996
-16% -$30.7K ﹤0.01% 1679
2022
Q1 		$248K Sell
12,731
-7,733
-38% -$117K ﹤0.01% 1611
2021
Q4 		$334K Sell
20,464
-3,087
-13% -$51.5K ﹤0.01% 1404
2021
Q3 		$656K Hold
23,551
– – ﹤0.01% 1039
2021
Q2 		$698K Sell
23,551
-4,701
-17% -$136K 0.01% 990
2021
Q1 		$790K Sell
28,252
-2,617
-8% -$72.4K 0.01% 881
2020
Q4 		$875K Buy
+30,869
New +$800K 0.01% 648

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Mercer Global Advisors's RVNC Position: Q4 2024 in Review

Mercer Global Advisors sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 10,278 shares — an estimated $53.4K sold.

Mercer Global Advisors first reported a position in RVNC in Q4 2020 and held it in 16 quarters. The position peaked at $875K in Q4 2020. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Mercer Global Advisors reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 10,278 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $53.4K.
  • Mercer Global Advisors first reported a position in Revance Therapeutics, Inc. in Q4 2020 and held it in 16 quarters.
  • Mercer Global Advisors's Revance Therapeutics, Inc. position peaked at $875K in Q4 2020.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Mercer Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.